Human Papillomavirus: Pathogenesis, Transmission, Role in Oropharyngeal Cancer and Cancer Prevention - On Demand Access
-
You must log in to register
- Member - $50
- Resident Member - Free!
- Allied Staff Member - $50
- Professional Staff Nonmember - $100
- Other Nonmember - $100
Human papillomavirus (HPV) is the one of the most common sexually transmitted infections in the U.S. While there are more than 200 human papillomaviruses, most people who are infected by HPV will clear the virus. However, infections with high-risk, long-lasting strains can result in cancer development. One of the most common sites of HPV-associated cancers is the oropharynx made up of the base of tongue, soft palate, palatine tonsils, lateral and posterior pharyngeal walls. Today, HPV-associated oropharyngeal cancer is one of the fastest-rising cancers in men. In this 60-minute webinar, participants will gain knowledge of the pathogenesis of HPV, including routes of transmission, epidemiology of HPV-associated oropharyngeal cancer – as well as its treatment and prognosis – and the role of vaccination as a preventive measure.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Review the virology of human papillomavirus (HPV) infections.
- Discuss the mechanisms by which HPV causes cancer.
- Explain the epidemiology of HPV-associated oropharyngeal cancer.
- Examine the comprehensive overview of the staging, treatment and prognosis of HPV-associated oropharyngeal cancer.
- Determine the role of vaccination as a preventative measure.
An Internet-based CDE/CME Activity
Original Release Date: August 23, 2023
Expiration Date: August 23, 2026
Estimated time to complete this educational activity: 1.0 hour
Method of participation: Self-Study
Rabie M. Shanti, DMD, MD
Rabie M. Shanti, DMD, MD, is a fellowship-trained and board-certified oral and maxillofacial surgeon at Rutgers Health. Dr. Shanti specializes in the evaluation and surgical management of benign and malignant tumors of the head and neck with a focus on oral cancer, oral potentially malignant disorders, benign tumors of the jaws and salivary gland tumors. He also specializes in the evaluation and management of inflammatory conditions of the jaws, such as osteoradionecrosis (ORN) and medicated-related osteonecrosis of the jaw (MRONJ). Dr. Shanti received his DMD (magna cum laude) from Harvard School of Dental Medicine and his MD from Rutgers New Jersey Medical School. He completed his oral and maxillofacial surgery residency at Rutgers Health/University Hospital and completed a two-year clinical fellowship in head and neck oncologic surgery/microvascular reconstruction at Louisiana State University Health Sciences, Shreveport. He has also completed a two-year research fellowship at the NIH. Dr. Shanti joined the faculty at the University of Pennsylvania, where he served as an Assistant Professor of Oral and Maxillofacial Surgery and Otorhinolaryngology/Head and Neck Surgery as well as the Associate Director of the Head and Neck Cancer Service Line. In 2022, Dr. Shanti returned to Rutgers University to serve as the Director of Maxillofacial Oncology and the Director of the Oral and Maxillofacial Surgery residency training program at Rutgers School of Dental Medicine. Dr. Shanti is involved in both clinical and translational research, and has published over 100 peer-reviewed publications and book chapters. He has been the recipient of several research grants from the NIH, OMS Foundation and Osteo Science Foundation for his research initiatives on oral oncology, ameloblastoma and regenerative medicine. He was the 2007 corecipient of the Daniel M. Laskin Award for the most outstanding article published in JOMS. Additionally, he has received multiple teaching awards for his commitment to the education of surgical residents, including the 2021 AAOMS Faculty Educator Development Award (FEDA).
Disclosures: No relevant financial relationships were disclosed.
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).
AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Key:
Complete
Next
Failed
Available
Locked